Thornberry Nancy
SEC CIK 1797826 · EDGAR
BoughtSold
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-04 17:02 | 2026-09-02 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | S - Sale | $22.90 | -11.4K | 19.7K | -37% | -$261.9K |
| D | 2026-06-23 16:28 | 2026-06-22 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +8,141 | 25.4K | +47% | $0 |
| D | 2026-06-05 16:45 | 2026-06-03 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +6,408 | 31.1K | +26% | $0 |
| D | 2026-05-05 17:37 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | Thornberry Nancy | Dir | A - Grant | $0.00 | +472 | 2,507 | +23% | $0 |
| D | 2026-05-05 17:37 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | Thornberry Nancy | Dir | D - Sale to Iss | — | -398 | 2,109 | -16% | — |
| D | 2025-06-20 | 2025-06-18 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +5,997 | 17.2K | +53% | $0 |
| D | 2025-06-05 | 2025-06-03 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +6,037 | 24.7K | +32% | $0 |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | Thornberry Nancy | Dir | A - Grant | $0.00 | +398 | 2,035 | +24% | $0 |
| D | 2024-06-20 | 2024-06-18 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +5,000 | 11.2K | +80% | $0 |
| D | 2024-06-04 | 2024-05-31 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +5,967 | 18.7K | +47% | $0 |
| D | 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | Thornberry Nancy | Dir | A - Grant | $0.00 | +501 | 1,637 | +44% | $0 |
| 2023-12-06 | 2023-12-05 | VRTX | Vertex Pharmaceuticals | Thornberry Nancy | Dir | A - Grant | $0.00 | +1,136 | 1,136 | New | $0 | |
| D | 2023-06-16 | 2023-06-15 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +6,250 | 6,250 | New | $0 |
| D | 2023-06-05 | 2023-06-01 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +4,216 | 12.7K | +50% | $0 |
| D | 2023-05-23 | 2023-05-22 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | M - OptEx | $11.52 | +14.8K | 14.8K | New | +$171.1K |
| D | 2023-05-23 | 2023-05-22 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | S - Sale+OE | $35.00 | -14.8K | 0 | -100% | -$519.8K |
| D | 2022-08-12 | 2022-08-11 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | S - Sale+OE | $35.00 | -4,950 | 0 | -100% | -$173.2K |
| D | 2022-08-12 | 2022-08-11 | SDGR | Schrodinger, Inc. | Thornberry Nancy | Dir | M - OptEx | $11.52 | +4,950 | 4,950 | New | +$57.0K |
| D | 2022-06-06 | 2022-06-02 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +5,986 | 8,497 | +238% | $0 |
| 2022-01-11 | 2022-01-08 | DNLI | Denali Therapeutics Inc. | Thornberry Nancy | Dir | A - Grant | $0.00 | +627 | 2,511 | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations